Antimalarial compounds in Phase II clinical development

Held, Jana; Jeyaraj, Sankarganesh; Kreidenweiss, Andrea

dc.contributor.author	Held, Jana
dc.contributor.author	Jeyaraj, Sankarganesh
dc.contributor.author	Kreidenweiss, Andrea
dc.date.accessioned	2015-04-16T09:00:07Z
dc.date.available	2015-04-16T09:00:07Z
dc.date.issued	2015
dc.identifier.issn	1354-3784
dc.identifier.uri	http://hdl.handle.net/10900/62809
dc.language.iso	en	de_DE
dc.publisher	Informa Healthcare	de_DE
dc.relation.uri	http://dx.doi.org/10.1517/13543784.2015.1000483	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Antimalarial compounds in Phase II clinical development	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150402110707_00030	de_DE
utue.publikation.seiten	363-382	de_DE
utue.personen.roh	Held, Jana
utue.personen.roh	Jeyaraj, Sankarganesh
utue.personen.roh	Kreidenweiss, Andrea
dcterms.isPartOf.ZSTitelID	Expert Opinion on Investigational Drugs	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	24	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE